rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Blake Aftab

Chief Scientific Officer

Company insider

Files Form 4 as: Chief Scientific Officer, Adicet Bio.

In numbers

Trades disclosed
44
Buys
0
Sells
6
Bought
$0
Sold
$564K
Companies
1
Companies where not an officer
0
First trade
12 Oct 2021
Last trade
19 Jun 2026
Last filed
23 Jun 2026

Companies traded

Where they are an officer
ACET Adicet BioOfficer · Biotechnology · last 19 Jun 20260 buys · 6 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
19 Jun 2026filed 23 Jun 2026ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—55,000 at $0.00filing
19 Jun 2026filed 23 Jun 2026ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—55,000 at $0.00filing
25 Mar 2026filed 27 Mar 2026ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—72,555 at $0.00filing
25 Mar 2026filed 27 Mar 2026ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—72,555 at $0.00filing
24 Jan 2026filed 27 Jan 2026ACET Adicet BioBiotechnologySEC FORM 4 Code F$4,515535 at $8.44filing
24 Jan 2026filed 27 Jan 2026ACET Adicet BioBiotechnologySEC FORM 4 Code F$4,515535 at $8.44filing
31 Jan 2025filed 4 Feb 2025ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—275,000 at $0.00filing
24 Jan 2025filed 28 Jan 2025ACET Adicet BioBiotechnologySEC FORM 4 Code F$5,7686,270 at $0.92filing
5 Jun 2024filed 7 Jun 2024ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—336,911 at $0.00filing
24 Jan 2024filed 26 Jan 2024ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—241,173 at $0.00filing
24 Jan 2024filed 26 Jan 2024ACET Adicet BioBiotechnologySEC FORM 4 Code F$8,5563,565 at $2.40filing
24 Jan 2024filed 26 Jan 2024ACET Adicet BioBiotechnologySEC FORM 4 Code A—19,700 at $0.00filing
12 Oct 2023filed 16 Oct 2023ACET Adicet BioBiotechnologySEC FORM 4 Code F$11K7,933 at $1.35filing
14 Aug 2023filed 16 Aug 2023ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code D—50,000 at $0.00filing
14 Aug 2023filed 16 Aug 2023ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
14 Aug 2023filed 16 Aug 2023ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code D—56,612 at $0.00filing
14 Aug 2023filed 16 Aug 2023ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—56,612 at $0.00filing
14 Aug 2023filed 16 Aug 2023ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code D—125,000 at $0.00filing
14 Aug 2023filed 16 Aug 2023ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—125,000 at $0.00filing
14 Aug 2023filed 16 Aug 2023ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code D—60,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care6

Buys in green, sells in red, by the company’s sector.

Related people

Lloyd KlicksteinChief Medical Officer · Chief Medical Officer at Adicet Bio, filing Form 4 there in the last year
Andrew SinclairDirector · Director at Adicet Bio, filing Form 4 there in the last year
Chen SchorPresident & CEO · President & CEO at Adicet Bio, filing Form 4 there in the last year
Steve DubinDirector · Director at Adicet Bio, filing Form 4 there in the last year
Katie PengDirector · Director at Adicet Bio, filing Form 4 there in the last year